Viewing StudyNCT00053027



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00053027
Status: COMPLETED
Last Update Posted: 2016-12-07
First Post: 2003-01-27

Brief Title: Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkins Lymphoma
Sponsor: Alliance for Clinical Trials in Oncology
Organization: Alliance for Clinical Trials in Oncology

Organization Data

Organization: Alliance for Clinical Trials in Oncology
Class: OTHER
Study ID: NCCTG-N0189
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Alliance for Clinical Trials in Oncology
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH